PROF Profound Medical Corp.

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:PRN.

$7.63  -0.16 (-2.05%)
As of 06/24/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  Canada
Country of incorporation:  
IPO date:  06/09/2016
Outstanding shares:  20,839,869
Average volume:  21,964
Market cap:   $162,342,580
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      40-F
Valuation   (See tab for details)
PE ratio:   -5.06
PB ratio:   2.13
PS ratio:   21.57
Return on equity:   -42.19%
Net income %:   -417.42%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy